Hearing loss in Iranian thalassemia major patients treated with deferoxamine: A systematic review and meta-analysis

Hearing loss in Iranian thalassemia major patients treated with deferoxamine: A systematic review and meta-analysis

Background: Hearing disorders are reported in thalassemia patients treated with deferoxamine. This study aimed to assess hearing loss in Iranian thalassemia major patients treated with deferoxamine. Methods: This review article was designed based on PRISMA guidelines. To review the literature, two r...

Full description

Bibliographic Details
Main Authors: Gholamreza Badfar, Akram Mansouri, Masoumeh Shohani, Hamid Karimi, Zahra Khalighi, Shoboo Rahmati, Ali Delpisheh, Yousef Veisani, Ali Soleymani, Milad Azami
Format: Article
Language:English
Published: Babol University of Medical Sciences 2017-07-01
Series:Caspian Journal of Internal Medicine
Subjects:
Hearing Loss
Thalassemia Major
Deferoxamine
Systematic Review
Meta-analysis
Iran
Online Access:http://caspjim.com/browse.php?a_code=A-10-509-2&slc_lang=en&sid=1

Internet

http://caspjim.com/browse.php?a_code=A-10-509-2&slc_lang=en&sid=1

Similar Items